Using a highly sensitive proximity qPCR immunoassay, we found significantly elevated VEGF levels in eAMD patients compared to healthy controls, with the highest levels observed in active cases with macular edema and lower levels in advanced atrophic stages. The gene discussed is VEGFA; the disease is macular retinal edema.